(1 - 18 von 21
)
Spiegel.de: Krebsforschung: Nur jeder zehnte Durchbruch wird weiterverfolgt - DER...
Selbst Forscher zeigen sich schockiert: Die wenigsten der als Durchbruch vermeldeten neuen Ansätze in der Krebstherapie werden nach Jahren tatsächlich weiter...
Spiegel.de: Reproducibility Initiative will Studien schneller überprüfen lassen -...
Mancher wissenschaftliche Durchbruch entpuppt sich als Reinfall. Ein US-Unternehmen bietet Forschern die Möglichkeit, ihre Arbeiten von anderen überprüfen zu...
In cancer science, many "discoveries" don't hold up | Reuters
www.reuters.com
A former researcher at Amgen Inc has found that many basic studies on cancer -- a high proportion of them from university labs -- are unreliable, with grim...
Velma C. Begley Obituary - Newspapers.com
www.newspapers.com
Clipping found in The Cincinnati Enquirer in Cincinnati, Ohio on Feb 4, Velma C. Begley Obituary
OBT Appoints C. Glenn Begley as a Senior Clinical Advisor and Non ...www.technologynetworks.com › o...
www.technologynetworks.com
C. Glenn Begley has over 10 years of experience in leading the strategy and co-ordination of Oncology Research at Amgen, and brings extensive knowledge ...
Bei Krebs wird oft wenig Substanzielles publiziert
www.aerztezeitung.de
Selbst wenn man die schwierigen Bedingungen der vorklinischen Forschung kennt, ist das ein schockierendes Ergebnis", schreiben die Forscher C. Glenn Begley von …
Monday Lunch Live with Dr C. Glenn Begley | | VCCC Alliance
vcccalliance.org.au
Glenn Begley will present the challenges and opportunities for drug discovery and development in Melbourne and Australia and how BioCurate was created to ...
Aspartam: Der Schlussstrich
www.strunz.com
Power Eiweiß, Nahrungsergzänzungsmittel und täglich aktuelle News rund um Ernährung und Bewegung direkt von Dr. Strunz
BioBriefing – A Fireside Chat with Dr Glenn Begley ...www.mtpconnect.org.au › Event
www.mtpconnect.org.au
Join Dr Krystal Evans in conversation with the CEO of BioCurate, Dr Glenn Begley and hear his views on the local and global biotech scene, his plans for ...
Transparenz-Initiative: FDA-Chef will präklinische Studien offenlegen
www.deutsche-apotheker-zeitung.de
Am Menschen durchgeführte klinische Studien müssen großteils registriert und veröffentlicht werden. Der neue Kommissar der amerikanischen Arzneimittelbehörde,...
FULLY BOOKED – BioBriefing – A Fireside Chat with Dr ...biomelbourne.org › event › biobriefing-a-firesid...
biomelbourne.org
Dr C. Glenn Begley is a clinical haematologist and medical oncologist, whose academic and commercial roles include board level and senior ...
BioCurate – turning discoveries into therapies - Peter Doherty ...www.doherty.edu.au › news-events › events › bi...
www.doherty.edu.au
Glenn Begley (CEO, BioCurate); Linda Peterson (COO, BioCurate); Catherine Drinkwater (Senior Project Leader, BioCurate); Lorna Mitchell ...
CEO Appointed to New Medicines Discovery Venture, BioCurate Pty Ltd
www.unimelb.edu.au
An outstanding industry leader with exceptional national and global experience in successfully propelling important biomedical discoveries out of the lab and...
CEO for BioCurate - Biotech
biotechdispatch.com.au
A CEO has been appointed to lead BioCurate, the $80 million venture launched last year by Monash University and the University of Melbourne and supported by...
Pfizer retractions point to the need for better research oversightmedcitynews.com › › pfiz...
medcitynews.com
C. Glenn Begley, former head of oncology and hematology research at Amgen, believes this latest example of flawed research is just the tip of ...
Man accused of choking victim in Evansville incident - Casper, WY Oil...
oilcity.news
A man is facing a felony strangulation charge, after it was alleged that he choked and struck a person he was sharing a hotel room with in Evansville.
Preclinical Data From Amgen's Oncology Pipeline to be Presented at...
investors.amgen.com
... to develop predictive or prognostic biomarkers," said C. Glenn Begley , M.D., vice president, Global Hematology and Oncology Research at Amgen . "This is ...
sortiert nach Relevanz / Datum